M&A Deal Summary |
|
|---|---|
| Date | 2017-09-18 |
| Target | Plan B One-Step |
| Sector | Life Science |
| Buyer(s) | Foundation Consumer Healthcare |
| Sellers(s) | Teva Pharmaceutical Industries |
| Deal Type | Divestiture |
| Deal Value | 675M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2014 |
| Sector | Medical Products |
Foundation Consumer Healthcare is dedicated to improving consumers’ lives by developing and growing a portfolio of differentiated over-the-counter (OTC) products. Foundation Consumer Healthcare was founded in 2014 and is based in Pittsburgh, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 2 |
| Country (Israel) | 1 of 1 |
| Year (2017) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-16 |
GSK Consumer Healthcare - seven brands
Brentford, United Kingdom GSK Consumer Healthcare's seven brands portfolio of products includes Breathe Right Nasal Strips and Children’s Dimetapp, pharmacist-recommended brand for children's cough and cold products, as well as Anbesol, Alavert, Dristan, Primatene Tablets and FiberCon. The addition of these brands will expand Foundation’s marketing presence to an additional 32 markets globally. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1901 |
| Sector | Life Science |
| Employees | 35,001 |
| Revenue | 15.8B USD (2023) |
Teva Pharmaceutical Industries is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 9 |
| Sector (Life Science) | 5 of 8 |
| Type (Divestiture) | 6 of 8 |
| Country (Israel) | 4 of 4 |
| Year (2017) | 2 of 2 |
| Size (of disclosed) | 3 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-09-11 |
Teva Pharmaceutical Industries - PARAGARD
Buffalo, New York, United States PARAGARD is a copper-releasing device that is placed in the uterus to prevent pregnancy for up to 10 years. |
Sell | $1.1B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-02-01 |
Thermamex
London, United Kingdom Theramex is a global specialty pharmaceutical company dedicated to women and their health. The Company markets a broad range of branded and branded generic products across 50 countries around the world. The portfolio, which is dedicated to women's health, focuses on contraception, fertility, menopause and osteoporosis and includes key brands such as Ovaleap®, Zoely®, Seasonique®, Actonel®, Estreva® and Lutenyl®. Thermamex is based in London, United Kingdom. |
Sell | $703M |
